Artwork

Contenido proporcionado por MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

Lessons from UKCTOCS, a large-scale trial in ovarian cancer screening

26:57
 
Compartir
 

Manage episode 399359963 series 1631392
Contenido proporcionado por MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
UKCTOCS (UK Collaborative Trial of Ovarian Cancer Screening) is one of the largest screening trials in ovarian cancer. More than 200,000 women from England, Wales and Northern Ireland took part in it, and it ran for almost two decades. Designing and running such a large and lengthy trial came with its own challenges. In this episode, Professor Usha Menon discusses the key challenges that UKCTOCS faced in its design, conduct an analysis, and how the team addressed them. Further information is available on the UKCTOCS website at https://ukctocs.mrcctu.ucl.ac.uk/ Listen to the episode about the UKCTOCS trial results at https://bit.ly/48pK94J For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk For more information and to access the transcript: https://bit.ly/45XRyWT As a listener, your opinion is very valuable to us. Please help us to improve the podcast in the future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g
  continue reading

25 episodios

Artwork
iconCompartir
 
Manage episode 399359963 series 1631392
Contenido proporcionado por MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente MRC CTU at UCL - Trial Talk podcast and MRC Clinical Trials Unit at UCL o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
UKCTOCS (UK Collaborative Trial of Ovarian Cancer Screening) is one of the largest screening trials in ovarian cancer. More than 200,000 women from England, Wales and Northern Ireland took part in it, and it ran for almost two decades. Designing and running such a large and lengthy trial came with its own challenges. In this episode, Professor Usha Menon discusses the key challenges that UKCTOCS faced in its design, conduct an analysis, and how the team addressed them. Further information is available on the UKCTOCS website at https://ukctocs.mrcctu.ucl.ac.uk/ Listen to the episode about the UKCTOCS trial results at https://bit.ly/48pK94J For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk For more information and to access the transcript: https://bit.ly/45XRyWT As a listener, your opinion is very valuable to us. Please help us to improve the podcast in the future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g
  continue reading

25 episodios

所有剧集

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida